In a new study, scientist Rajiv K. Saxena and his team investigated the potential of nanodiamonds in combating tumor metastasis.
A group of researchers found that nanoparticles called “extracellular vesicles” (EVs) released by cells have the ability to reduce the infectiousness of SARS-CoV-2, including both wild-type and variant strains, as well as possibly other infectious diseases.
Cornell Prime Dots, also called C’Dots, are ultrasmall fluorescent core-shell hybrid silica nanoparticles that have been thought to only be effective when administered intravenously. However, recent studies have demonstrated the possibility of administering them orally.
Recently, a multinational team, including researchers from EPFL, devised a protocol facilitating a molecular network equipped with multiple transmitters.
The IBEC is poised to take charge of coordinating the PHOTOTHERAPORT project, which is slated for development with financial support from the European Innovation Council's Pathfinder Open program.
Proteins that aggregate into clumps are common culprits in challenging-to-treat conditions like ALS, Alzheimer’s, and Parkinson's. Investigating how these proteins interact has historically been a complex task.
Venous abnormalities, comprising tissues primarily composed of abnormally shaped veins, can pose significant challenges for treatment, particularly when situated in sensitive areas such as the eyes, face, and genitourinary organs.
There was a widespread belief in the invincibility against bacterial diseases, all thanks to antibiotics. Despite the easy availability of antibiotic treatments, countless lives are lost to invisible pathogens. The challenge of creating drugs capable of fighting resistant bacterial strains has not kept up with the rapid spread of resistance.
A new grant will support scientists in investigating how nanoparticles interact with the immune system and cancer so that new drug delivery systems can be developed.
One of the deadliest tumors that affect people is pancreatic cancer. In the Western world, it ranks as the fourth most common cause of cancer-related fatalities. Since the disease frequently progresses in its early stages without symptoms, diagnosis occurs much later.